Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-12-16
pubmed:abstractText
To evaluate the relationship between vascular endothelial growth factor (VEGF) and extracellular superoxide dismutase (EC-SOD) in vitreous body and serum in patients with proliferative diabetic retinopathy (PDR), and investigate the role of EC-SOD in PDR by evaluating its angiostatic effect, using an in vitro angiogenesis model. To investigate the role of EC-SOD in PDR by evaluating its angiostatic effect, using an in vitro angiogenesis model.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-10168890, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-10450379, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-10780101, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-11113458, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-11596663, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-11719508, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-11742414, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-11834254, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-12480817, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-12885586, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-14573788, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-1505778, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-15370362, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-15615788, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-1592880, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-16026270, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-16410812, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-18314536, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-19369240, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-2479987, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-6823562, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-7786032, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-7988042, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-8107827, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-8660335, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-9129943, http://linkedlifedata.com/resource/pubmed/commentcorrection/20011081-9436620
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1090-0535
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2663-72
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients.
pubmed:affiliation
Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu Pharmaceutical University, Mitahora-higashi, Japan.
pubmed:publicationType
Journal Article